Sustainability & Climate

A new gene therapy that reprograms cancer cells into immune activators shows major promise, blending personalized treatment with off-the-shelf convenience.

A landmark real-world study from England shows maternal RSV vaccination slashes infant hospitalizations, validating a powerful new shield for newborns.

A new joint venture will build four advanced hybrid tugs for Woodside's massive LNG terminal, signaling a major investment in sustainable maritime tech.

A $2.5M gift honors a legacy and empowers a top scientist to develop imaging tech that could revolutionize how we diagnose and treat blindness.

New data reveals a novel cancer drug shrinks brain metastases in over half of small cell lung cancer patients, offering hope where options are scarce.

MLB legend Darryl Strawberry shares his recovery journey, highlighting Gaudenzia's fight against addiction amidst a regional public health crisis.

A new platform watches individual tumor cells to link behavior with biology, offering a powerful tool against treatment resistance in cancers like glioblastoma.

While national reading scores falter, a Mississippi school sees 63% of its most challenged readers make gains. Here's how they are doing it.

Interim trial data shows IPH5201 plus durvalumab yields pathological complete response rates up to 50%, far surpassing current standards for resectable NSCLC.

New data on ATX-295 reveals a potent attack on unstable tumors, guided by an AI biomarker that could change how we select patients for treatment.

Nested Therapeutics' NST-628 reports a 38% response rate in advanced melanoma, offering new hope with a novel, brain-penetrating cancer-fighting agent.

New guidelines advise biennial screening for women 50-74 and caution for others, a move that has drawn sharp criticism from other medical bodies.

For the first time, a major regulatory body has approved a drug name created by AI, signaling a new era for the highly regulated pharmaceutical industry.

Dr. Jennifer Shuford, a crisis-tested leader from Texas, is named CDC Deputy Director, a move experts hope will stabilize the beleaguered agency.

As EXEED unveils its new robots, a deeper look reveals a strategy to move beyond cars, deploying autonomous helpers in public services across the globe.

The University of Virginia is launching an AI lab that goes beyond code, using a liberal arts focus to teach ethical and critical use of technology.

New clinical consensus on ammonia and scrutiny of a standard antibiotic are creating a perfect storm for Yaqrit's promising new liver disease treatments.

As EBONY marks its 80th anniversary, the iconic Power 100 list returns with public nominations, aiming to redefine influence and celebrate a new generation.

Brunswick's Freedom Boat Club just bought its largest franchise, signaling a strategic consolidation and a major bet on the 'boating-as-a-service' model.

At AACR 2026, CREATE Medicines debuts its RetroT platform, an all-RNA system for stable gene delivery that avoids viral vectors and reshapes cell therapy.